Microbot Medical Inc. (NASDAQ: MBOT) has entered into an agreement with Lovell Government Services to distribute its LIBERTY Endovascular Robotic System across federal healthcare networks, according to a press release from the company.

Under the agreement, Lovell Government Services will serve as Microbot Medical's Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor, enabling access to facilities operated by the Veterans Health Administration, the Military Health System, and the U.S. Indian Health Service. The arrangement covers more than 2,000 government facilities.

The LIBERTY System will be added to Lovell's Federal Supply Schedule contract, with activation expected in the third quarter of 2026. The product will also be listed on GSA Advantage, the Defense Logistics Agency's Electronic Catalog, and the Department of Defense's Distribution and Pricing Agreement.

Lovell Government Services has held SDVOSB vendor status since 2013 and serves thousands of government care sites nationwide, including 170 medical centers. The company has been named to the Inc. 5000 list four times.

"We are proud to partner with Microbot Medical to help expand access to innovative healthcare technologies for our nation's veterans, active-duty service members, and Native American communities," said Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services.